Eris Lifesciences Ltd.

₹1464.6

Eris Lifesciences Ltd.

₹1464.6

₹1464.6

-17.8 (-1.2%) - 17 May 2025 04:23 PM

About Company

Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti–diabetes; vitamins; gastroenterology and gynaecology. The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Market Cap. ₹ 19,946 Cr.
52 Week - High/Low ₹ 1,594/816
P/E Ratio 233.82
P/B Ratio 8.00
Enterprise Value ₹ 19,148 Cr.
ROE % 12.65
RSI Value 69.22
EMA 50 1397.12
EMA 200 1288.95
Market Cap. ₹ 19,946 Cr.
52 Week - High/Low ₹ 1,594/816
P/E Ratio 61.26
P/B Ratio 7.81
Enterprise Value ₹ 19,772 Cr.
ROE % 16.63
RSI Value 69.22
EMA 50 1397.12
EMA 200 1288.95

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.